PURPOSE: To develop and evaluate fully automated volumetric modulated arc therapy (VMAT) treatment planning for prostate cancer patients, avoiding manual trial-and-error tweaking of plan parameters by dosimetrists. METHODS AND MATERIALS: A system was developed for fully automated generation of VMAT plans with our commercial clinical treatment planning system (TPS), linked to the in-house developed Erasmus-iCycle multicriterial optimizer for preoptimization. For 30 randomly selected patients, automatically generated VMAT plans (VMATauto) were compared with VMAT plans generated manually by 1 expert dosimetrist in the absence of time pressure (VMATman). For all treatment plans, planning target volume (PTV) coverage and sparing of organs-at-risk were quantified. RESULTS: All generated plans were clinically acceptable and had similar PTV coverage (V95% > 99%). For VMATauto and VMATman plans, the organ-at-risk sparing was similar as well, although only the former plans were generated without any planning workload. CONCLUSIONS: Fully automated generation of high-quality VMAT plans for prostate cancer patients is feasible and has recently been implemented in our clinic.
PURPOSE: To develop and evaluate fully automated volumetric modulated arc therapy (VMAT) treatment planning for prostate cancerpatients, avoiding manual trial-and-error tweaking of plan parameters by dosimetrists. METHODS AND MATERIALS: A system was developed for fully automated generation of VMAT plans with our commercial clinical treatment planning system (TPS), linked to the in-house developed Erasmus-iCycle multicriterial optimizer for preoptimization. For 30 randomly selected patients, automatically generated VMAT plans (VMATauto) were compared with VMAT plans generated manually by 1 expert dosimetrist in the absence of time pressure (VMATman). For all treatment plans, planning target volume (PTV) coverage and sparing of organs-at-risk were quantified. RESULTS: All generated plans were clinically acceptable and had similar PTV coverage (V95% > 99%). For VMATauto and VMATman plans, the organ-at-risk sparing was similar as well, although only the former plans were generated without any planning workload. CONCLUSIONS: Fully automated generation of high-quality VMAT plans for prostate cancerpatients is feasible and has recently been implemented in our clinic.
Authors: J M A M Kusters; K Bzdusek; P Kumar; P G M van Kollenburg; M C Kunze-Busch; M Wendling; T Dijkema; J H A M Kaanders Journal: Strahlenther Onkol Date: 2017-08-02 Impact factor: 3.621
Authors: Masoud Zarepisheh; Linda Hong; Ying Zhou; Jung Hun Oh; James G Mechalakos; Margie A Hunt; Gig S Mageras; Joseph O Deasy Journal: Med Phys Date: 2019-05-29 Impact factor: 4.071
Authors: Abdul Wahab M Sharfo; Sebastiaan Breedveld; Peter W J Voet; Sabrina T Heijkoop; Jan-Willem M Mens; Mischa S Hoogeman; Ben J M Heijmen Journal: PLoS One Date: 2016-12-29 Impact factor: 3.240
Authors: Daniel Buergy; Abdul Wahab M Sharfo; Ben J M Heijmen; Peter W J Voet; Sebastiaan Breedveld; Frederik Wenz; Frank Lohr; Florian Stieler Journal: Radiat Oncol Date: 2017-01-31 Impact factor: 3.481
Authors: Giuseppe Della Gala; Maarten L P Dirkx; Nienke Hoekstra; Dennie Fransen; Nico Lanconelli; Marjan van de Pol; Ben J M Heijmen; Steven F Petit Journal: Strahlenther Onkol Date: 2017-03-17 Impact factor: 3.621
Authors: Martin Buschmann; Abdul Wahab M Sharfo; Joan Penninkhof; Yvette Seppenwoolde; Gregor Goldner; Dietmar Georg; Sebastiaan Breedveld; Ben J M Heijmen Journal: Strahlenther Onkol Date: 2017-12-21 Impact factor: 3.621